Semax vs GHRP-6
A comprehensive, data-driven comparison of Semax and GHRP-6 (Growth Hormone Releasing Peptide-6). Compare efficacy, side effects, costs, FDA approval status, and clinical evidence to make an informed decision.
Side-by-Side Comparison
| Property | Semax | GHRP-6 Growth Hormone Releasing Peptide-6 |
|---|---|---|
| FDA Status | Not submitted | Not submitted |
| Category | Cognitive Enhancement | Growth Hormone |
| Primary Use | Cognitive enhancement and neuroprotection | Growth hormone optimization |
| Weight Loss % | N/A | N/A |
| Monthly Cost | $45 - $90/mo | $35 - $70/mo |
| Administration | Nasal spray | Subcutaneous injection |
| Typical Dose | 2-3 drops per nostril 2-3x daily | 100-300mcg 2-3x daily |
| Frequency | Daily | Daily |
| Mechanism | Synthetic ACTH analog that enhances BDNF production, improves cerebral circulation, and protects neurons | First-generation growth hormone secretagogue that stimulates GH release and increases appetite via ghrelin mimicry |
| Common Side Effects |
|
|
| Serious Side Effects |
|
|
| Evidence Quality | Moderate | Emerging |
| Clinical Trial Phase | N/A | N/A |
Key Differences
- 1GHRP-6 is generally more affordable ($35 - $70/mo) compared to Semax ($45 - $90/mo).
- 2Semax is administered via nasal spray, while GHRP-6 uses subcutaneous injection.
- 3Semax has moderate-quality evidence, while GHRP-6 has emerging-quality evidence.
- 4They belong to different categories: Semax (Cognitive Enhancement) vs GHRP-6 (Growth Hormone).
Which Is Better For...
GHRP-6
More budget-friendly option with lower monthly costs
Semax
Fewer commonly reported side effects
Semax
Stronger clinical evidence base to support its use
Cost Comparison
| Peptide | Monthly Cost Range | FDA Status | Manufacturer |
|---|---|---|---|
| Semax | $45 - $90/mo | Not submitted | Various research labs |
| GHRP-6 | $35 - $70/mo | Not submitted | Various research labs |
Prices are estimated monthly costs and may vary based on pharmacy, insurance coverage, and manufacturer assistance programs. Costs for non-FDA-approved peptides reflect research compound pricing.
Frequently Asked Questions
Semax works via Synthetic ACTH analog that enhances BDNF production, improves cerebral circulation, and protects. GHRP-6 works via First-generation growth hormone secretagogue that stimulates GH release and increases appetite via. They differ in FDA approval status, efficacy data, and cost.
Semax typically costs $45 - $90/mo, while GHRP-6 costs $35 - $70/mo. Prices may vary by pharmacy, insurance coverage, and manufacturer programs.
Semax is not FDA-approved (Not submitted). GHRP-6 is not FDA-approved (Not submitted). FDA approval indicates the treatment has met rigorous safety and efficacy standards.
Common side effects of Semax include Nasal irritation, Mild stimulation, Headache. Common side effects of GHRP-6 include Significant increase in appetite, Water retention, Tingling or numbness. Always consult a healthcare provider about potential side effects.
Switching between peptide therapies should only be done under the guidance of a qualified healthcare provider. They can evaluate your medical history, current response, and determine the safest transition protocol.
Learn More
Semax is a synthetic peptide analog of adrenocorticotropic hormone (ACTH) developed in Russia. It has been shown to increase brain-derived neurotrophic factor (BDNF), improve cerebral blood flow, and ...
View Full Semax GuideGHRP-6 is a synthetic hexapeptide and one of the first growth hormone releasing peptides developed. It stimulates GH secretion by activating the ghrelin receptor. Unlike later-generation peptides like...
View Full GHRP-6 GuideOther Popular Comparisons
Medical Disclaimer
The information provided on this page is for educational and informational purposes only and does not constitute medical advice. This comparison between Semax and GHRP-6 should not be used as a substitute for professional medical guidance. Always consult a qualified healthcare provider before starting, stopping, or modifying any peptide therapy. Clinical data cited may be from ongoing trials and is subject to change. Individual results may vary significantly. PeptideVS does not endorse, recommend, or promote the use of any specific peptide for medical treatment.